We’re seeing euphoria based on greed, not fundamentals. You need to rebalance your portfolio. Read More

Marijuana companies are having trouble raising capital. Here’s what you need to know, to pick the ultimate survivors of pot's financial crisis. Read More

During the holiday season in Q4 2018, the stock market tanked and finished the year lower. Conditions are lining up for a repeat. Read More

Due to an accounting blunder, NV5 misstated earnings guidance for next year and its stock tanked. Here's how our expert plans to cash in. Read More

Amid a fuzzy backdrop, investors lack clarity about the market’s direction. We sharpen the lens for a better picture. Read More

The S&P 500 Dividend Aristocrats index shows how stocks with growing dividends can boost total returns over time. Read More

Marijuana infrastructure stocks can be highly profitable, but you must separate the weak from the strong. Here's how. Read More

Readers in recent days posed questions on a range of timely investment topics. You have questions, we have answers. Read More

Aramco's massive IPO is scheduled to occur next month. The event raises the question, how can investors properly value a company? Read More

Sentiment is getting whipsawed by uncertainties over trade war, earnings, and global growth. Here are six steps to take. Read More